Biobased factor VIII therapies in hemophilia A patients
- Universiteit Universiteit Utrecht
- Promovendus Anouk Donners
- Promoters Toine Egberts
- Co-Promoters Karin Rademaker Erik van Maarseveen
- Jaar 2018 - 2022
The landscape of drug development as well as clinical practice has been changing over the last decennium, with the increasing availability and use of biobased therapies. This research is now focusing on the use and therapeutic drug monitoring of biobased factor VIII therapies in hemophilia A patients.